Key predictors of long-term outcomes in BCMA-targeted CAR-T therapy for relapsed/refractory multiple myeloma

Abstract Background B-cell maturation antigen (BCMA)-directed chimeric antigen receptor T-cell (CAR-T) therapy exhibits high response rates in patients with relapsed/refractory multiple myeloma (r/r MM). However, the specific factors that influence the response duration remain poorly understood. Met...

Description complète

Détails bibliographiques

Auteurs principaux:	Ning An, Juan Li, Pan Luo, Di Wang, Peiling Zhang, Chang Shu, Songbai Cai, Qiuxia Yu, Xinyu Wen, Xinran Wang, Wei Mu, Jianlin Hu, Chunrui Li
Format:	Artigo
Langue:	Inglês
Publié:	BMC 2025-05-01
Collection:	Journal of Translational Medicine
Sujets:	R/R multiple myeloma BCMA CAR-T MRD CAR-T cell
Accès en ligne:	https://doi.org/10.1186/s12967-025-06543-x
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!